Obesity
A primer on GLP-1 receptor agonists for weight loss
From diabetes to weight loss, GLP-1 receptor agonists are considered to be revolutionary treatments with high patient interest
It is estimated that the prevalence of adult obesity has doubled since 1990. Along with this, the number of people diagnosed with type 2 diabetes has also increased. These statistics are behind a concentrated research effort to develop new therapies that can treat both conditions. Specifically, the development of GLP-1 receptor agonists such as Mounjaro, Ozempic, Wegovy and more, have radically changed the landscape for diabetes and weight management. These medicines are the most popular prescriptions of 2024 with sales measured in the billions of dollars.
When it comes to promoting weight loss, GLP-1 (which stands for glucagon-like peptide-1) receptor agonists work by regulating a person's appetite. This happens because GLP-1s improve blood sugar control. When blood sugar is stable, a person feels less cravings for food. In addition, the absorption of glucose into the bloodstream is also slowed down. As a result of this effect, it takes longer for the stomach to empty after a meal. This makes someone feel more 'full' and for a longer period of time, decreasing the desire to eat.
Though this class of drug has received a lot of attention and interest from consumers, they are not entirely new. It was during the 1980s that the GLP-1 hormone and its role in regulating blood sugar was identified. In the early 2000s, the first GLP-1 agonist was developed to treat diabetes. Since then, many improvements have been made. In the early days of GLP-1, daily injections (two) were required. Nowadays, fewer injections may be needed; in some cases, a pill form is available.
In 2014 a GLP-1 for weight management was approved. In 2021 when Semaglutide was approved to treat obesity, public attention and interest skyrocketed. Since that time, new GLP-1s such as Tirzepatide have become available, giving patients and their providers more options to consider to aid in the achievement of weight loss.
GLP-1 agonists all share a common mechanism of action, but they differ in other key areas such as dosing frequency. So, what are some of the most popular GLP-1 options?
Semaglutide (brand names: Wegovy, Ozempic, Rybelsus)
Wegovy (weight loss) and Ozempic (type 2 diabetes) are available as a weekly injection while Rybelsus, for management of type 2 diabetes, is a daily tablet taken by mouth.
In terms of promoting weight loss, Wegovy is typically prescribed for obese adults (BMI over 30), and overweight adults (BMI over 27) with additional health issues such as high blood pressure or elevated cholesterol. Wegovy should be used in conjunction with a reduced-calorie diet and increased physical activity to achieve weight loss.
Liraglutide (brand names: Victoza, Saxenda)
Saxenda (weight loss) and Victoza (type 2 diabetes) are both available as a daily injection.
Saxenda can be effective for weight loss when also combined with a reduced-calorie diet and increased physical activity. Adults taking the medicine for weight loss were shown to experience a weight loss of about 8% of their starting weight.
Dulaglutide (brand name: Trulicity)
This weekly injection is taken to help manage type 2 diabetes.
Exenatide (the first GLP-1; brand names: Byetta, Bydureon)
Both are taken for the management of type 2 diabetes; Byetta is a twice-daily injection while Bydureon is a once-weekly injection.
Ultimately the choice of medication by a physician is based on individual patient needs and preferences. Today there is ongoing research into this class of drugs to enhance their effectiveness and potentially reduce side effects. In addition, researchers are looking at combinations of GLP-1s with other medicines to provide novel treatments to patients with other conditions or multiple health challenges.
The evolution of GLP-1 agonists from diabetes treatments to broader reaching therapies illustrates a significant impact on medical science and patient care. Want to learn more? Be sure to talk to your healthcare provider!
Published Date July 31, 2024
Latest News
Leukemia (AML)
A simple guide to understanding chemo
Chemo is an effective cancer treatment - but what is it exactly and why does it work?
2024-12-09T14:25:00Z
Eczema
Self-care tips during eczema flare-ups
Eczema can be emotionally draining and physically uncomfortable - learn how self-care can change your outlook
2024-11-26T18:46:00Z
Healthy Volunteers
What is a Phase 1 trial?
Phase 1 trials are necessary first steps on the road to clinical breakthroughs and healthy volunteers can help make these a reality.
2024-11-11T15:35:00Z
Colorectal Cancer
The role of biomarker testing in cancer
Biomarkers can play important roles in cancer treatment, but what are they and what can they tell doctors?
2024-10-16T18:18:00Z
Hypertension
Home-based exercise tips for blood pressure control
Getting heart-healthy physical activity doesn't have to mean running a marathon or joining an expensive gym.
2024-09-08T18:30:00Z
Leukemia (AML)
What helps with nausea besides medicine?
Nausea is an unfortunate aspect of cancer treatment - what may help reduce this side effect?
2024-08-31T18:30:00Z
Healthy Volunteers
Common misconceptions about clinical research
Many people have never participated in a clinical trial so it can be hard to separate fact from myth - here are some of the most common myths debunked.
2024-08-28T21:23:00Z
Obesity
The basics of BMI
BMI, or Body Mass Index, is a standard way to assess weight status - learn why and where it came from
2024-08-22T13:50:00Z
Colorectal Cancer
Why is Colorectal Cancer striking at younger ages?
The number of people being diagnosed with colorectal cancer under the age of 50 has greatly increased - what might be the cause of this troubling trend?
2024-08-14T16:12:00Z
Hypertension
Four foods linked with lower blood pressure
While the foods you eat can raise the risk of developing hypertension, there are also options that can help lower blood pressure.
2024-08-01T18:30:00Z
Obesity
A primer on GLP-1 receptor agonists for weight loss
An overview on select GLP-1 receptor agonist treatments that help promote blood sugar management and weight loss
2024-07-31T18:30:00Z
Multiple Myeloma
Life with a rare disease
Experiencing serious health challenges is difficult enough - having a relatively unknown condition adds additional complexity
2024-07-08T22:02:00Z
Eczema
Atopic Dermatitis: signs and stages
Understanding how atopic dermatitis looks, feels and changes during a flare-up is helpful to patients seeking greater control of their condition
2024-07-01T16:12:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Speaking with your PCP about MASH
Engaging your primary doctor in a conversation about risk for MASH liver disease doesn't have to be scary
2024-06-25T12:15:00Z
Alzheimer's Disease
New Alzheimer’s Disease research breakthroughs
The 2020s have been the most impactful decade so far for the debilitating form of dementia
2024-05-02T18:30:00Z
Breast Cancer
Talking to family about cancer genes
Though this conversation may be difficult, it might be vitally important for your loved ones
2024-02-05T18:30:00Z
Lupus
Lupus (Systemic Lupus Erythematosus) and Diet
Can what you eat make a difference?
2024-04-15T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Learning you need a liver biopsy: staying calm
Approaches to stay in control before, during and after a biopsy
2023-12-27T18:30:00Z
Diabetes
The recent rise of walking as exercise
Grab your sneakers, grab a friend, or grab your dog and get moving!
2023-12-05T18:30:00Z
Renal Cell Carcinoma
Coping with the holidays during cancer treatment
Getting ready to face a new year while facing cancer is no easy task
2023-11-23T18:30:00Z
Multiple Sclerosis (MS)
Possible link between multiple sclerosis and viral infection?
Researchers are looking to learn more about if and how a virus can trigger multiple sclerosis
2023-10-25T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Losing excess weight together with an active lifestyle helps with the management of MASH, but where to begin?
2023-09-05T18:30:00Z
Lung Cancer
Talking to loved ones about your clinical trial
How to talk to family and friends when you are thinking of changing cancer treatment plans for a research option
2023-08-14T18:30:00Z
Lung Cancer
Learning you have lung cancer as a non-smoker
Lung cancer can be a shocking diagnosis when you've never smoked - how can it be?
2023-08-15T18:30:00Z
Prostate Cancer
Does a high PSA score always mean cancer?
Learn more about this common test for older men and how it relates to cancer risk
2023-07-10T18:30:00Z
Breast Cancer
Understanding the differences between mastectomy and lumpectomy
Two different surgical options both seeking the same outcome
2023-07-07T18:30:00Z
Lupus
New treatments are on the horizon for lupus patients
From biologics to CAR-T, developments in clinical research for SLE have opened new treatment doors for patients.
2023-05-22T16:15:00Z
Multiple Myeloma
Understanding eligibility criteria for clinical research studies
Clinical trials utilize sets of criteria to determine if a person is a good fit - but what are these and what do they mean?
2023-04-05T18:30:00Z
Renal Cell Carcinoma
Learning you need a biopsy: staying calm
Approaches to stay in control before, during and after a diagnostic biopsy
2023-03-14T18:30:00Z
Metabolic dysfunction-associated steatohepatitis (MASH)
Making lifestyle changes: ten ideas to get started
Pharmaceutical companies are rushing to fill the NASH treatment gap
2023-03-14T18:30:00Z